|
A Report from the 2007 San Antonio Breast Cancer Symposium
This program will provide an update on clinical evidence for the treatment of patients with early and metastatic breast cancer. Two nationally recognized oncology experts present a concise review of recent clinical data presented at the 2007 San Antonio Breast Cancer Symposium and provide recommendations regarding the application of recent findings into clinical practice.
Early Breast Cancer Treatment
|
 |
Maura N. Dickler, MD
Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
Topics include:
- 21-gene recurrence score assay
- 7-year update AC vs. TC
- Endocrine therapy: 100 month update (ATAC)
- Effects of endocrine therapy on bone health
- Prevention of AI-induced bone loss (bisphosphonates, denosumab)
|
Metastatic Breast Cancer
Treatment
|
 |
William J. Gradishar, MD, FACP
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Topics include:
- Gemcitabine/docetaxel vs. capecitabine/docetaxel
- Ixabepilone/capecitabine in ER/PR/HER2-negative MBC
- Trastuzumab beyond progression
- EGFR-targeted therapy
|
Available until February 2009, this activity offers:
Physicians: 1 AMA PRA Category 1 Credit™
Nurses: 1 contact hour
Pharmacists: 1 contact hour (0.1 CEU)
[Back to top]
[Back to Activity Home]
|
